Page 139 - Aet News Today

The Federal Trade Commission is suing to stop Amgen’s acquisition of Horizon Therapeutics. But rather than claiming product overlap, the agency contends Amgen will use its influence to keep at bay competition for Horizon’s products.

Metaphore Biotechnologies leverages the concept of biomimicry for developing new drugs with potential applications in autoimmune diseases, metabolic disorders, and cancer. Flagship Pioneering is backing the startup with $50 million.

Afentra (LON:AET – Get Rating)‘s stock had its “buy” rating reissued by Peel Hunt in a note issued to investors on Tuesday, MarketBeat reports. Afentra Trading Up 2.4 % Shares of Afentra stock traded up GBX 0.63 ($0.01) during trading on Tuesday, reaching GBX 26.43 ($0.33). The company’s stock had a trading volume of 810,537 […]

Ascertain — a healthcare AI company creation platform formed last year by Northwell Health and Aegis Ventures — has launched its first startup. New York-based Optain, which has gained an initial seed investment of $12 million, is an AI company meant to enable earlier disease detection and prevention through retinal imaging.

Patients can now find and book urgent care appointments in 22 states at more than 200 facilities on Zocdoc's marketplace. In 2023, the company saw the volume of new urgent care facilities on Zocdoc grow by nearly 40% month over month on average and urgent care bookings grow by 80% month over month on average.

Hippocratic AI emerged from stealth, as well as announced $50 million in seed funding through a round co-led by General Catalyst and Andreessen Horowitz. The Palo Alto-based startup bills itself as the first large language model designed specifically for healthcare.

As we consider the ramifications of the President’s cancellation of the Pandemic emergency, we have time to reflect on the transformation of the 3 P’s of healthcare: People, Policies and Politics.

On the surface, it sounds like one of the simplest procedures undertaken at a health system: answering the phone. But anyone who works at a health system knows it is not that simple.

One in four providers said that health technology vendors haven’t kept their promises in the past year. KLAS Research debunked four common misconceptions vendors may have about why so many providers feel this way — such as the false notion that employees who weren't part of the purchasing decision feel the most disappointed by vendors or the misbelief that it's better to not make promises in the first place.

When we bring physicians from underserved communities into research through a reimagined model, we can impact better health outcomes rooted in quality data that allows us to thrive from more diversity and better representation while providing patients with greater access to new care options.